UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Publication bias in recent meta-analyses

PloS one, 2013-11, Vol.8 (11), p.e81823-e81823

2013

Volltextzugriff (PDF)

Correction: Publication Bias in Recent Meta-Analyses

PloS one, 2014-01, Vol.9 (1)

2014

Volltextzugriff (PDF)

An epidemiological appraisal of the association between heart rate variability and particulate air pollution: a meta-analysis

Heart (British Cardiac Society), 2012-08, Vol.98 (15), p.1127-1135

2012

Volltextzugriff (PDF)

Child's buccal cell mitochondrial DNA content modifies the association between heart rate variability and recent air pollution exposure at school

Environment international, 2019-02, Vol.123, p.39-49

2019

Volltextzugriff (PDF)

Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype

Haematologica (Roma), 2019-06, Vol.104 (6), p.1168-1175

2019

Volltextzugriff (PDF)

How does under-reporting of negative and inconclusive results affect the false-positive rate in meta-analysis? A simulation study

BMJ open, 2014-08, Vol.4 (8), p.e004831-e004831

Kicinski, Michal

2014

Volltextzugriff (PDF)

Prognostic and predictive value of an immune-related adverse event among stage III melanoma patients included in the EORTC 1325/KEYNOTE-054 pembrolizumab versus placebo trial

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.2517-2517

2019

Volltextzugriff (PDF)

Immunoglobulin Heavy Chain High-Throughput Sequencing in Pediatric B-Precursor Acute Lymphoblastic Leukemia: Is the Clonality of the Disease at Diagnosis Related to Its Prognosis?

Frontiers in pediatrics, 2022-05, Vol.10, p.874771-874771

2022

Volltextzugriff (PDF)

Publication bias in meta-analyses from the Cochrane Database of Systematic Reviews

Statistics in medicine, 2015-09, Vol.34 (20), p.2781-2793

2015

Volltextzugriff (PDF)

Correction: Publication Bias in Recent Meta-Analyses

PloS one, 2013-12, Vol.8 (12)

2013

Volltextzugriff (PDF)

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

The lancet oncology, 2021-05, Vol.22 (5), p.643-654

2021

Volltextzugriff (PDF)

Phase III study of adjuvant encorafenib plus binimetinib versus placebo in fully resected stage IIB/C BRAFV600-mutated melanoma: COLUMBUS-AD study design

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS9601-TPS9601

2023

Volltextzugriff (PDF)

Retinal microvascular responses to short-term changes in particulate air pollution in healthy adults

Environmental health perspectives, 2013-09, Vol.121 (9), p.1011-1016

2013

Volltextzugriff (PDF)

Estimation of Distant Metastasis–free Survival in Trials of Adjuvant Therapy for Melanoma

The New England journal of medicine, 2019-04, Vol.380 (14), p.1374-1377

2019

Volltextzugriff (PDF)

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial

The lancet oncology, 2021-05, Vol.22 (5), p.655-664

2021

Volltextzugriff (PDF)

Lower placental telomere length may be attributed to maternal residential traffic exposure; a twin study

Environment international, 2015-06, Vol.79, p.1-7

2015

Volltextzugriff (PDF)

Neurobehavioral performance in adolescents is inversely associated with traffic exposure

Environment international, 2015-02, Vol.75, p.136-143

2015

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Aktive Filter

KollektionSpringer Nature - Complete Springer Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(69)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Publication bias in recent meta-analyses

Correction: Publication Bias in Recent Meta-Analyses

An epidemiological appraisal of the association between heart rate variability and particulate air pollution: a meta-analysis

Child's buccal cell mitochondrial DNA content modifies the association between heart rate variability and recent air pollution exposure at school

Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype

Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma: New recurrence-free survival results from the EORTC 1325-MG/Keynote 054 double-blinded phase III trial at three-year median follow-up

How does under-reporting of negative and inconclusive results affect the false-positive rate in meta-analysis? A simulation study

Sociodemographic and Medical Determinants of Quality of Life in Long-Term Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC CLG Studies

Prognostic and predictive value of an immune-related adverse event among stage III melanoma patients included in the EORTC 1325/KEYNOTE-054 pembrolizumab versus placebo trial

Immunoglobulin Heavy Chain High-Throughput Sequencing in Pediatric B-Precursor Acute Lymphoblastic Leukemia: Is the Clonality of the Disease at Diagnosis Related to Its Prognosis?

Publication bias in meta-analyses from the Cochrane Database of Systematic Reviews

Correction: Publication Bias in Recent Meta-Analyses

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial

Phase III study of adjuvant encorafenib plus binimetinib versus placebo in fully resected stage IIB/C BRAFV600-mutated melanoma: COLUMBUS-AD study design

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial

Retinal microvascular responses to short-term changes in particulate air pollution in healthy adults

Estimation of Distant Metastasis–free Survival in Trials of Adjuvant Therapy for Melanoma

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial

Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced BRAF -V600E/K-mutated melanoma: The primary analysis of an EORTC randomized phase II study (EBIN)

Lower placental telomere length may be attributed to maternal residential traffic exposure; a twin study

Neurobehavioral performance in adolescents is inversely associated with traffic exposure

Measurable Residual Disease Assessment in Patients with Acute Myeloid Leukemia Aged ≥60 Years Treated with a 10-Day Decitabine Schedule Versus Intensive Chemotherapy in the AML21 Study (NCT02172872)

Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma

Aktive Filter

Suchergebnisse filtern